CoChat

Combating Antibiotic Resistance: Mechanisms, Multidrug-Resistant Pathogens, and Novel Therapeutic Approaches: An Updated Review

Elshobary, Mostafa E., Badawy, Nadia K., Ashraf, Yara, Zatioun, Asmaa A., Masriya, Hagar H., Ammar, Mohamed M., Mohamed, Nourhan A., Mourad, Sohaila, Assy, Abdelrahman M. · 2025 · Pharmaceuticals
Cited by 268

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

The escalating global health crisis of antibiotic resistance, driven by the rapid emergence of multidrug-resistant (MDR) bacterial pathogens, necessitates urgent and innovative countermeasures. This review comprehensively examines the diverse mechanisms employed by bacteria to evade antibiotic action, including alterations in cell membrane permeability, efflux pump overexpression, biofilm formation, target site modifications, and the enzymatic degradation of antibiotics. Specific focus is given to membrane transport systems such as ATP-binding cassette (ABC) transporters, resistance–nodulation–division (RND) efflux pumps, major facilitator superfamily (MFS) transporters, multidrug and toxic compound extrusion (MATE) systems, small multidrug resistance (SMR) families, and proteobacterial antimicrobial compound efflux (PACE) families. Additionally, the review explores the global burden of MDR pathogens and evaluates emerging therapeutic strategies, including quorum quenching (QQ), probiotics, postbiotics, synbiotics, antimicrobial peptides (AMPs), stem cell applications, immunotherapy, antibacterial photodynamic therapy (aPDT), and bacteriophage. Furthermore, this review discusses novel antimicrobial agents, such as animal-venom-derived compounds and nanobiotics, as promising alternatives to conventional antibiotics. The interplay between clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated proteins (Cas) in bacterial adaptive immunity is analyzed, revealing opportunities for targeted genetic interventions. By synthesizing current advancements and emerging strategies, this review underscores the necessity of interdisciplinary collaboration among biomedical scientists, researchers, and the pharmaceutical industry to drive the development of novel antibacterial agents. Ultimately, this comprehensive analysis provides a roadmap for future research, emphasizing the urgent need for sustainable and cooperative approaches to combat antibiotic resistance and safeguard global health.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ph18030402

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 199

  1. Zhao, 2021, Glutamine Promotes Antibiotic Uptake to Kill Multidrug-Resistant Uropathogenic Bacteria, Sci. Transl. Med., 13, eabj0716, 10.1126/scitranslmed.abj0716 · DOI · Paper page
  2. Islam, M.A., Islam, M.R., Khan, R., Amin, M.B., Rahman, M., Hossain, M.I., Ahmed, D., Asaduzzaman, M., and Riley, L.W. (2022). Prevalence, Etiology and Antibiotic Resistance Patterns of Community-Acquired Urinary Tract Infections in Dhaka, Bangladesh. PLoS ONE, 17. · DOI
  3. Safdar, N., Zahra, A., Komal, S., Ul Ain, Q., and Mazhar, M. (2023). The Trend of Antibiotic Resistance In the Era of COVID-19 and Its Trailing. SSRN J. · doi:10.2139/ssrn.4511574
  4. El-Sapagh, S., El-Shenody, R., Pereira, L., and Elshobary, M. (2023). Unveiling the Potential of Algal Extracts as Promising Antibacterial and Antibiofilm Agents against Multidrug-Resistant Pseudomonas aeruginosa: In Vitro and In Silico Studies Including Molecular Docking. Plants, 12. · DOI
  5. Osei Sekyere, J., Kerdsin, A., Chopjitt, P., and Wendling, C.C. (2023). Editorial: Community Series—Characterization of Mobile Genetic Elements Associated with Acquired Resistance Mechanisms, Volume II. Front. Microbiol., 14. · DOI
  6. Günther, T., Kramer-Schadt, S., Fuhrmann, M., and Belik, V. (2022). Environmental Factors Associated with the Prevalence of ESBL/AmpC-Producing Escherichia coli in Wild Boar (Sus scrofa). Front. Vet. Sci., 9. · DOI
  7. Lee, 2022, Membrane Vesicles from Antibiotic-Resistant Staphylococcus aureus Transfer Antibiotic-Resistance to Antibiotic-Susceptible Escherichia coli, J. Appl. Microbiol., 132, 2746, 10.1111/jam.15449 · DOI
  8. Terefinko, 2023, Removal of Clinically Significant Antibiotics from Aqueous Solutions by Applying Unique High-Throughput Continuous-Flow Plasma Pencil and Plasma Brush Systems, Chem. Eng. J., 452, 139415, 10.1016/j.cej.2022.139415 · DOI
  9. Zhou, 2022, A Survey of Helicobacter pylori Antibiotic-Resistant Genotypes and Strain Lineages by Whole-Genome Sequencing in China, Antimicrob. Agents Chemother., 66, e02188-21, 10.1128/aac.02188-21 · DOI
  10. Alam, 2021, Prevalence of Multidrug Resistance Bacterial Isolates from Infected Wound Patients in Dhaka, Bangladesh: A Cross-Sectional Study, Int. J. Surg. Open, 28, 56, 10.1016/j.ijso.2020.12.010 · DOI
  11. Nocera, F.P., Ambrosio, M., Fiorito, F., Cortese, L., and De Martino, L. (2021). On Gram-Positive- and Gram-Negative-Bacteria-Associated Canine and Feline Skin Infections: A 4-Year Retrospective Study of the University Veterinary Microbiology Diagnostic Laboratory of Naples, Italy. Animals, 11. · DOI
  12. Wang, 2019, Impact of Antimicrobial Stewardship Managed by Clinical Pharmacists on Antibiotic Use and Drug Resistance in a Chinese Hospital, 2010–2016: A Retrospective Observational Study, BMJ Open, 9, e026072, 10.1136/bmjopen-2018-026072 · DOI · Paper page
  13. Pulingam, 2021, Antimicrobial Resistance: Prevalence, Economic Burden, Mechanisms of Resistance and Strategies to Overcome, Eur. J. Pharm. Sci., 170, 106103, 10.1016/j.ejps.2021.106103 · DOI · Paper page
  14. Shrestha, 2018, Enumerating the Economic Cost of Antimicrobial Resistance per Antibiotic Consumed to Inform the Evaluation of Interventions Affecting Their Use, Antimicrob. Resist. Infect. Control, 7, 98, 10.1186/s13756-018-0384-3 · DOI · Paper page
  15. Li, 2022, Bacterial Resistance to Antibacterial Agents: Mechanisms, Control Strategies, and Implications for Global Health, Sci. Total Environ., 860, 160461, 10.1016/j.scitotenv.2022.160461 · DOI
  16. Hosny, S., Elshobary, M.E., and El-Sheekh, M.M. (2025). Unleashing the Power of Microalgae: A Pioneering Path to Sustainability and Achieving the Sustainable Development Goals. Environ. Sci. Pollut. Res., 1–31. · DOI
  17. Theuretzbacher, 2020, Critical Analysis of Antibacterial Agents in Clinical Development, Nat. Rev. Microbiol., 18, 286, 10.1038/s41579-020-0340-0 · DOI · Paper page
  18. Outterson, 2021, Estimating the Appropriate Size of Global Pull Incentives For Antibacterial Medicines: Study Examines Global Antibacterial Pull Incentives, Health Aff., 40, 1758, 10.1377/hlthaff.2021.00688 · DOI
  19. Balasegaram, 2020, Antibiotic Development—Economic, Regulatory and Societal Challenges, Nat. Rev. Microbiol., 18, 267, 10.1038/s41579-019-0293-3 · DOI · Paper page
  20. Blind, K. (2023). The Overall Impact of Economic, Social and Institutional Regulation on Innovation: An Update. Handbook of Innovation and Regulation, Edward Elgar Publishing. · doi:10.4337/9781800884472.00020
  21. Pierce, 2022, Post-COVID-19 Syndrome, Nurs. Res., 71, 164, 10.1097/NNR.0000000000000565 · DOI
  22. Smith, 2023, Bacterial Defences: Mechanisms, Evolution and Antimicrobial Resistance, Nat. Rev. Microbiol., 21, 519, 10.1038/s41579-023-00877-3 · DOI · Paper page
  23. Sakagianni, A., Koufopoulou, C., Koufopoulos, P., Kalantzi, S., Theodorakis, N., Nikolaou, M., Paxinou, E., Kalles, D., Verykios, V.S., and Myrianthefs, P. (2024). Data-Driven Approaches in Antimicrobial Resistance: Machine Learning Solutions. Antibiotics, 13. · DOI
  24. Abushaheen, 2020, Antimicrobial Resistance, Mechanisms and Its Clinical Significance, Disease-a-Month, 66, 100971, 10.1016/j.disamonth.2020.100971 · DOI · Paper page
  25. Andrade, 2023, Serratia marcescens Antibiotic Resistance Mechanisms of an Opportunistic Pathogen: A Literature Review, PeerJ, 11, e14399, 10.7717/peerj.14399 · DOI
  26. Lade, H., and Kim, J.-S. (2023). Molecular Determinants of β-Lactam Resistance in Methicillin-Resistant Staphylococcus aureus (MRSA): An Updated Review. Antibiotics, 12. · DOI · Paper page
  27. Tierney, 2022, Stochastic Activation of a Family of TetR Type Transcriptional Regulators Controls Phenotypic Heterogeneity in Acinetobacter baumannii, PNAS Nexus, 1, pgac231, 10.1093/pnasnexus/pgac231 · DOI
  28. Esau, V.C.-Z. (2023). Structure-Activity Relationship Between Klebsiella pneumoniae β-Lactamase CTX-M-15 and Selected β-Lactam Antibiotics: Evaluating the Binding Site Promiscuity. [Master’s Thesis, University of the Witwatersrand].
  29. Miller, 2016, Vancomycin-Resistant Enterococci: Therapeutic Challenges in the 21st Century, Infect. Dis. Clin., 30, 415
  30. Lewis, 2017, New Approaches to Antimicrobial Discovery, Biochem. Pharmacol., 134, 87, 10.1016/j.bcp.2016.11.002 · DOI
  31. Singh, 2022, Regulation of Small RNA-Mediated High Temperature Stress Responses in Crop Plants, Plant Cell Rep., 41, 765, 10.1007/s00299-021-02745-x · doi:10.1007/s00299-021-02745-x
  32. Rodríguez-Núñez, K., Cortés-Monroy, A., Serey, M., Ensari, Y., Davari, M.D., Bernal, C., and Martinez, R. (2023). Modulating Substrate Specificity of Rhizobium Sp. Histamine Dehydrogenase Through Protein Engineering for Food Quality Applications. Molecules, 28. · doi:10.3390/molecules28093748
  33. Kakoullis, L., Papachristodoulou, E., Chra, P., and Panos, G. (2021). Mechanisms of Antibiotic Resistance in Important Gram-Positive and Gram-Negative Pathogens and Novel Antibiotic Solutions. Antibiotics, 10. · DOI · Paper page
  34. De Gaetano, G.V., Lentini, G., Famà, A., Coppolino, F., and Beninati, C. (2023). Antimicrobial Resistance: Two-Component Regulatory Systems and Multidrug Efflux Pumps. Antibiotics, 12. · DOI
  35. Scoffone, V.C., Trespidi, G., Barbieri, G., Arshad, A., Israyilova, A., and Buroni, S. (2025). The Evolution of Antimicrobial Resistance in Acinetobacter baumannii and New Strategies to Fight It. Antibiotics, 14. · DOI
  36. Zakaria, N.F.S., Yahya, M.F.Z.R., and Jamil, N.M. (2023). Multiple Bacterial Strategies to Survive Antibiotic Pressure: A Review. Preprints. · DOI
  37. Belay, W.Y., Getachew, M., Tegegne, B.A., Teffera, Z.H., Dagne, A., Zeleke, T.K., Abebe, R.B., Gedif, A.A., Fenta, A., and Yirdaw, G. (2024). Mechanism of Antibacterial Resistance, Strategies and Next-Generation Antimicrobials to Contain Antimicrobial Resistance: A Review. Front. Pharmacol., 15. · DOI · Paper page
  38. Henderson, 2019, Coupling Efficiency of Secondary Active Transporters, Curr. Opin. Biotechnol., 58, 62, 10.1016/j.copbio.2018.11.005 · DOI
  39. Li, 2023, Identification and Characterization of a Novel Major Facilitator Superfamily Efflux Pump, SA09310, Mediating Tetracycline Resistance in Staphylococcus aureus, Antimicrob. Agents Chemother., 67, e01696-22, 10.1128/aac.01696-22 · DOI
  40. Nag, 2021, A Major Facilitator Superfamily (MFS) Efflux Pump, SCO4121, from Streptomyces coelicolor with Roles in Multidrug Resistance and Oxidative Stress Tolerance and Its Regulation by a MarR Regulator, Appl. Environ. Microbiol., 87, e02238-20, 10.1128/AEM.02238-20 · DOI
  41. Vrancianu, C.O., Gheorghe, I., Czobor, I.B., and Chifiriuc, M.C. (2020). Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii. Microorganisms, 8. · DOI · Paper page
  42. Corral, 2019, Roles of Efflux Pumps from Different Superfamilies in the Surface-Associated Motility and Virulence of Acinetobacter baumannii ATCC 17978, Antimicrob. Agents Chemother., 63, e02190-18, 10.1128/AAC.02190-18 · doi:10.1128/aac.02190-18
  43. Teng, D., and Voth, G.A. (2023). Ligand Binding by the Small Multidrug-Resistant Transporter EmrE. Biophys. J., 122. · doi:10.1016/j.bpj.2022.11.2183
  44. Guérin, F., Galimand, M., Tuambilangana, F., Courvalin, P., and Cattoir, V. (2014). Overexpression of the Novel MATE Fluoroquinolone Efflux Pump FepA in Listeria monocytogenes Is Driven by Inactivation of Its Local Repressor FepR. PLoS ONE, 9. · DOI
  45. Miyauchi, 2017, Structural Basis for Xenobiotic Extrusion by Eukaryotic MATE Transporter, Nat. Commun., 8, 1633, 10.1038/s41467-017-01541-0 · DOI
  46. Kim, J., Cater, R.J., Choy, B.C., and Mancia, F. (2021). Structural Insights into Transporter-Mediated Drug Resistance in Infectious Diseases. J. Mol. Biol., 433. · DOI · Paper page
  47. Stephen, J., Lekshmi, M., Ammini, P., Kumar, S.H., and Varela, M.F. (2022). Membrane Efflux Pumps of Pathogenic Vibrio Species: Role in Antimicrobial Resistance and Virulence. Microorganisms, 10. · DOI
  48. Hassan, 2018, Pacing across the Membrane: The Novel PACE Family of Efflux Pumps Is Widespread in Gram-Negative Pathogens, Res. Microbiol., 169, 450, 10.1016/j.resmic.2018.01.001 · DOI · Paper page
  49. Javed, W. (2020). Study of the Conformational States of a Bacterial Multidrug ABC Transporter BmrA. [Ph.D. Thesis, Université Grenoble Alpes].
  50. Migliaccio, A., Esposito, E.P., Bagattini, M., Berisio, R., Triassi, M., De Gregorio, E., and Zarrilli, R. (2022). Inhibition of AdeB, AceI, and AmvA Efflux Pumps Restores Chlorhexidine and Benzalkonium Susceptibility in Acinetobacter baumannii ATCC 19606. Front. Microbiol., 12. · DOI
  51. Labby, 2016, Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives, Medchemcomm, 7, 11, 10.1039/C5MD00344J · DOI · Paper page
  52. Nikaido, 2018, RND Transporters in the Living World, Res. Microbiol., 169, 363, 10.1016/j.resmic.2018.03.001 · DOI · Paper page
  53. Yamasaki, S., Zwama, M., Yoneda, T., Hayashi-Nishino, M., and Nishino, K. (2023). Drug Resistance and Physiological Roles of RND Multidrug Efflux Pumps in Salmonella enterica, Escherichia coli and Pseudomonas aeruginosa: This Article Is Part of the Antimicrobial Efflux Collection. Microbiology, 169. · DOI
  54. Lyu, 2022, Structural Basis of Peptide-Based Antimicrobial Inhibition of a Resistance-Nodulation-Cell Division Multidrug Efflux Pump, Microbiol. Spectr., 10, e02990-22, 10.1128/spectrum.02990-22 · DOI
  55. Ghai, I. (2024). Electrophysiological Insights into Antibiotic Translocation and Resistance: The Impact of Outer Membrane Proteins. Membranes, 14. · DOI
  56. Ghai, I. (2023). A Barrier to Entry: Examining the Bacterial Outer Membrane and Antibiotic Resistance. Appl. Sci., 13. · DOI
  57. Elshobary, M.E., Ebaid, R., Alquraishi, M., and Ende, S.S. (2025). Synergistic Microalgal Cocultivation: Boosting Flocculation, Biomass Production, and Fatty Acids Profile of Nannochloropsis oculata and Phaeodactylum tricornutum. Biomass Bioenergy, 193. · DOI
  58. Ahsan, A., Thomas, N., Barnes, T.J., Subramaniam, S., Loh, T.C., Joyce, P., and Prestidge, C.A. (2024). Lipid Nanocarriers-Enabled Delivery of Antibiotics and Antimicrobial Adjuvants to Overcome Bacterial Biofilms. Pharmaceutics, 16. · DOI
  59. Parvin, N., Joo, S.W., and Mandal, T.K. (2025). Nanomaterial-Based Strategies to Combat Antibiotic Resistance: Mechanisms and Applications. Antibiotics, 14. · DOI · Paper page
  60. Chaudhari, R., Singh, K., and Kodgire, P. (2022). Biochemical and Molecular Mechanisms of Antibiotic Resistance in Salmonella spp.. Res. Microbiol., 174. · DOI
  61. Mahdally, N.H., George, R.F., Kashef, M.T., Al-Ghobashy, M., Murad, F.E., and Attia, A.S. (2021). Staquorsin: A Novel Staphylococcus aureus Agr-Mediated Quorum Sensing Inhibitor Impairing Virulence In Vivo Without Notable Resistance Development. Front. Microbiol., 12. · DOI
  62. Gbian, D.L., and Omri, A. (2021). The Impact of an Efflux Pump Inhibitor on the Activity of Free and Liposomal Antibiotics Against Pseudomonas aeruginosa. Pharmaceutics, 13. · doi:10.3390/pharmaceutics13040577
  63. Lopez-Fernandez, M., Westmeijer, G., Turner, S., Broman, E., Ståhle, M., Bertilsson, S., and Dopson, M. (2023). Thiobacillus as a Key Player for Biofilm Formation in Oligotrophic Groundwaters of the Fennoscandian Shield. npj Biofilms Microbiomes, 9. · DOI
  64. Li, 2021, Biological and Physiochemical Methods of Biofilm Adhesion Resistance Control of Medical-Context Surface, Int. J. Biol. Sci., 17, 1769, 10.7150/ijbs.59025 · DOI
  65. Xu, Y., Zeng, C., Wen, H., Shi, Q., Zhao, X., Meng, Q., Li, X., and Xiao, J. (2023). Discovery of AI-2 Quorum Sensing Inhibitors Targeting the LsrK/HPr Protein–Protein Interaction Site by Molecular Dynamics Simulation, Virtual Screening, and Bioassay Evaluation. Pharmaceuticals, 16. · DOI
  66. Fatima, M., Amin, A., Alharbi, M., Ishtiaq, S., Sajjad, W., Ahmad, F., Ahmad, S., Hanif, F., Faheem, M., and Khalil, A.A.K. (2023). Quorum Quenchers from Reynoutria japonica in the Battle against Methicillin-Resistant Staphylococcus aureus (MRSA). Molecules, 28. · DOI
  67. Shi, Q., Wen, H., Xu, Y., Zhao, X., Zhang, J., Li, Y., Meng, Q., Yu, F., Xiao, J., and Li, X. (2023). Virtual Screening–Based Discovery of AI-2 Quorum Sensing Inhibitors That Interact with an Allosteric Hydrophobic Site of LsrK and Their Functional Evaluation. Front. Chem., 11. · DOI
  68. Zhao, X., Yu, Z., and Ding, T. (2020). Quorum-Sensing Regulation of Antimicrobial Resistance in Bacteria. Microorganisms, 8. · DOI · Paper page
  69. Yin, 2022, 3-Phenylpropan-1-Amine Enhanced Susceptibility of Serratia Marcescens to Ofloxacin by Occluding Quorum Sensing, Microbiol. Spectr., 10, e01829-22, 10.1128/spectrum.01829-22 · DOI
  70. Hoang, 2023, Modulation of the Bacterial Virulence and Resistance by Well-Known European Medicinal Herbs, J. Ethnopharmacol., 312, 116484, 10.1016/j.jep.2023.116484 · DOI
  71. Patel, 2025, Combatting Antibiotic Resistance by Exploring the Promise of Quorum Quenching in Targeting Bacterial Virulence, Microbe, 6, 100224, 10.1016/j.microb.2024.100224 · DOI
  72. Qin, X., Vila-Sanjurjo, C., Singh, R., Philipp, B., and Goycoolea, F.M. (2020). Screening of Bacterial Quorum Sensing Inhibitors in a Vibrio Fischeri LuxR-Based Synthetic Fluorescent E. Coli Biosensor. Pharmaceuticals, 13. · DOI
  73. Mirpour, M., and Zahmatkesh, H. (2024). Ketoprofen Attenuates Las/Rhl Quorum-Sensing (QS) Systems of Pseudomonas aeruginosa: Molecular and Docking Studies. Mol. Biol. Rep., 51. · DOI
  74. Saeed, A., Ali, H., Yasmin, A., Baig, M., Ullah, A., Kazmi, A., Ahmed, M.A., Albadrani, G.M., El-Demerdash, F.M., and Bibi, M. (2023). Unveiling the Antibiotic Susceptibility and Antimicrobial Potential of Bacteria from Human Breast Milk of Pakistani Women: An Exploratory Study. BioMed Res. Int., 2023. · DOI
  75. Lin, 2021, Probiotic Bacillus Affects Enterococcus faecalis Antibiotic Resistance Transfer by Interfering with Pheromone Signaling Cascades, Appl. Environ. Microbiol., 87, e00442-21, 10.1128/AEM.00442-21 · DOI
  76. Khalil, T., Okla, M.K., Al-Qahtani, W.H., Ali, F., Zahra, M., Shakeela, Q., Ahmed, S., Akhtar, N., AbdElgawad, H., and Asif, R. (2024). Tracing Probiotic Producing Bacterial Species from Gut of Buffalo (Bubalus bubalis), South-East-Asia. Braz. J. Biol., 84. · doi:10.1590/1519-6984.259094
  77. Wang, S., Zhang, M., Yu, L., Tian, F., Lu, W., Wang, G., Chen, W., Wang, J., and Zhai, Q. (2022). Evaluation of the Potential Protective Effects of Lactobacillus Strains Against Helicobacter pylori Infection: A Randomized, Double-Blinded, Placebo-Controlled Trial. Can. J. Infect. Dis. Med. Microbiol., 2022. · DOI
  78. Pike, 2021, Exploring the Genomic Diversity and Antimicrobial Susceptibility of Bifidobacterium pseudocatenulatum in a Vietnamese Population, Microbiol. Spectr., 9, e00526-21, 10.1128/Spectrum.00526-21 · DOI
  79. Wu, Y., Wang, Y., Hu, A., Shu, X., Huang, W., Liu, J., Wang, B., Zhang, R., Yue, M., and Yang, C. (2022). Lactobacillus plantarum-Derived Postbiotics Prevent Salmonella-Induced Neurological Dysfunctions by Modulating Gut–Brain Axis in Mice. Front. Nutr., 9. · DOI
  80. Badr, 2021, Effects of the Prebiotic Lactoferrin on Multidrug-Resistant Escherichia coli Infections in Broiler Chickens, Vet. World, 14, 2197, 10.14202/vetworld.2021.2197-2205 · DOI
  81. Kaczmarczyk, M., Szulińska, M., Łoniewski, I., Kręgielska-Narożna, M., Skonieczna-Żydecka, K., Kosciolek, T., Bezshapkin, V., and Bogdański, P. (2022). Treatment with Multi-Species Probiotics Changes the Functions, Not the Composition of Gut Microbiota in Postmenopausal Women with Obesity: A Randomized, Double-Blind, Placebo-Controlled Study. Front. Cell. Infect. Microbiol., 12. · DOI
  82. Kumar, 2022, In Vitro Screening for Potential Probiotic Properties of Ligilactobacillus salivarius Isolated from Cattle Calves, Curr. Res. Biotechnol., 4, 275, 10.1016/j.crbiot.2022.06.001 · DOI
  83. Abraham, 2022, Bacillus Strains from the Ovaries of Swiss Albino Mice (Mus musculus): Deciphering of Probiotic Potential through an in Vitro Approach, Biomedicine, 42, 1200, 10.51248/.v42i6.2302 · DOI
  84. Rodríguez-Sorrento, A., Castillejos, L., López-Colom, P., Cifuentes-Orjuela, G., Rodríguez-Palmero, M., Moreno-Muñoz, J.A., and Martín-Orúe, S.M. (2020). Effects of Bifidobacterium longum Subsp. Infantis CECT 7210 and Lactobacillus rhamnosus HN001, Combined or Not with Oligofructose-Enriched Inulin, on Weaned Pigs Orally Challenged with Salmonella typhimurium. Front. Microbiol., 11. · DOI
  85. Lockyer, 2019, Prebiotics—An Added Benefit of Some Fibre Types, Nutr. Bull., 44, 74, 10.1111/nbu.12366 · DOI
  86. Huang, F.-C., and Huang, S.-C. (2021). The Combined Beneficial Effects of Postbiotic Butyrate on Active Vitamin D3-Orchestrated Innate Immunity to Salmonella Colitis. Biomedicines, 9. · DOI
  87. Salemi, 2023, Lactobacillus rhamnosus GG Cell-Free Supernatant as a Novel Anti-Cancer Adjuvant, J. Transl. Med., 21, 195, 10.1186/s12967-023-04036-3 · DOI
  88. Huang, 2020, Beneficial Effect of Probiotics on Pseudomonas aeruginosa–Infected Intestinal Epithelial Cells through Inflammatory IL-8 and Antimicrobial Peptide Human Beta-Defensin-2 Modulation, Innate Immun., 26, 592, 10.1177/1753425920959410 · DOI
  89. Gu, 2023, Characterization of Leuconostoc mesenteroides MJM60376 as an Oral Probiotic and Its Antibiofilm Activity, Mol. Oral Microbiol., 38, 145, 10.1111/omi.12397 · DOI
  90. Zhang, Q., Zhao, W., Zhao, Y., Duan, S., Liu, W.-H., Zhang, C., Sun, S., Wang, T., Wang, X., and Hung, W.-L. (2022). In Vitro Study of Bifidobacterium lactis BL-99 with Fructooligosaccharide Synbiotics Effected on the Intestinal Microbiota. Front. Nutr., 9. · DOI
  91. Geng, 2023, In Vitro Screening of Synbiotics Composed of Lactobacillus Paracasei VL8 and Various Prebiotics and Mechanism to Inhibits the Growth of Salmonella typhimurium, LWT, 180, 114666, 10.1016/j.lwt.2023.114666 · DOI
  92. Piatek, J., Krauss, H., Ciechelska-Rybarczyk, A., Bernatek, M., Wojtyla-Buciora, P., and Sommermeyer, H. (2020). In-Vitro Growth Inhibition of Bacterial Pathogens by Probiotics and a Synbiotic: Product Composition Matters. Int. J. Environ. Res. Public Health, 17. · DOI
  93. Daca, 2020, Therapeutic Methods of Gut Microbiota Modification in Colorectal Cancer Management—Fecal Microbiota Transplantation, Prebiotics, Probiotics, and Synbiotics, Gut Microbes, 11, 1518, 10.1080/19490976.2020.1764309 · DOI · Paper page
  94. Sommermeyer, H., Pituch, H.M., Wultanska, D., Wojtyla-Buciora, P., Piatek, J., and Bernatek, M. (2021). Inhibition of Quinolone- and Multi-Drug-Resistant Clostridioides Difficile Strains by Multi Strain Synbiotics—An Option for Diarrhea Management in Nursing Facilities. Int. J. Environ. Res. Public Health, 18. · DOI
  95. Gugjoo, 2023, Mesenchymal Stem Cells: A Promising Antimicrobial Therapy in Veterinary Medicine, Microb. Pathog., 182, 106234, 10.1016/j.micpath.2023.106234 · DOI
  96. Cardoso, 2022, Dissecting the Relationship between Antimicrobial Peptides and Mesenchymal Stem Cells, Pharmacol. Ther., 233, 108021, 10.1016/j.pharmthera.2021.108021 · DOI
  97. Gupta, 2023, CXCR4 Expression Is Elevated in TNBC Patient Derived Samples and Z-Guggulsterone Abrogates Tumor Progression by Targeting CXCL12/CXCR4 Signaling Axis in Preclinical Breast Cancer Model, Environ. Res., 232, 116335, 10.1016/j.envres.2023.116335 · DOI
  98. Chinipardaz, Z., Zhong, J.M., and Yang, S. (2022). Regulation of LL-37 in Bone and Periodontium Regeneration. Life, 12. · DOI
  99. McCulloch, 2022, Towards Efficient Immunotherapy for Bacterial Infection, Trends Microbiol., 30, 158, 10.1016/j.tim.2021.05.005 · DOI
  100. Ye, 2024, Influencing Immunity: Role of Extracellular Vesicles in Tumor Immune Checkpoint Dynamics, Exp. Mol. Med., 56, 2365, 10.1038/s12276-024-01340-w · DOI
  101. Pang, 2019, Sono-immunotherapeutic Nanocapturer to Combat Multidrug-resistant Bacterial Infections, Adv. Mater., 31, 1902530, 10.1002/adma.201902530 · DOI · Paper page
  102. Wang, 2022, Branched AuAg Nanoparticles Coated by Metal–Phenolic Networks for Treating Bacteria-Induced Periodontitis via Photothermal Antibacterial and Immunotherapy, Mater. Des., 224, 111401, 10.1016/j.matdes.2022.111401 · DOI
  103. Mitton, 2008, A Brief Overview of Photodynamic Therapy in Europe, Photodiagn. Photodyn. Ther., 5, 103, 10.1016/j.pdpdt.2008.04.004 · DOI
  104. Shih, Y.-H., Yu, C.-C., Chang, K.-C., Tseng, Y.-H., Li, P.-J., Hsia, S.-M., Chiu, K.-C., and Shieh, T.-M. (2022). Synergistic Effect of Combination of a Temoporfin-Based Photodynamic Therapy with Potassium Iodide or Antibacterial Agents on Oral Disease Pathogens In Vitro. Pharmaceuticals, 15. · DOI
  105. Liu, 2022, Synergistic Gentamicin-Photodynamic Therapy against Resistant Bacteria in Burn Wound Infections, Photodiagn. Photodyn. Ther., 39, 103034, 10.1016/j.pdpdt.2022.103034 · DOI
  106. Liu, 2020, Synergistic Antimicrobial Effects of Photodynamic Antimicrobial Chemotherapy and Gentamicin on Staphylococcus aureus and Multidrug-Resistant Staphylococcus aureus, Photodiagn. Photodyn. Ther., 30, 101703, 10.1016/j.pdpdt.2020.101703 · DOI
  107. Yang, 2013, Photodynamic Inactivation of Chlorin E6-loaded CTAB-liposomes against Candida albicans, Lasers Surg. Med., 45, 175, 10.1002/lsm.22124 · DOI
  108. Wainwright, 2017, Photoantimicrobials—Are We Afraid of the Light?, Lancet Infect. Dis., 17, e49, 10.1016/S1473-3099(16)30268-7 · DOI · Paper page
  109. Sperandio, 2013, Antimicrobial Photodynamic Therapy to Kill Gram-Negative Bacteria, Recent Pat. Anti-Infect. Drug Discov., 8, 108, 10.2174/1574891X113089990012 · DOI · Paper page
  110. Li, 2013, Effects of 5-Aminolevulinic Acid–Mediated Photodynamic Therapy on Antibiotic-Resistant Staphylococcal Biofilm: An in Vitro Study, J. Surg. Res., 184, 1013, 10.1016/j.jss.2013.03.094 · DOI
  111. Vasconcelos, 2017, Photodynamic Therapy Using. Chloro-Aluminum Phthalocyanine Decreases Inflammatory Response in an Experimental Rat. Periodontal Disease Model, J. Photochem. Photobiol. B Biol., 167, 208, 10.1016/j.jphotobiol.2016.12.031 · DOI
  112. Kamruzzaman, M., and Iredell, J.R. (2020). CRISPR-Cas System in Antibiotic Resistance Plasmids in Klebsiella pneumoniae. Front. Microbiol., 10. · DOI
  113. Tao, 2022, Association of CRISPR-Cas System with the Antibiotic Resistance and Virulence Genes in Nosocomial Isolates of Enterococcus, Infect. Drug Resist., 15, 6939, 10.2147/IDR.S388354 · DOI
  114. Greene, 2018, CRISPR-Based Antibacterials: Transforming Bacterial Defense into Offense, Trends Biotechnol., 36, 127, 10.1016/j.tibtech.2017.10.021 · DOI
  115. Wu, Y., Battalapalli, D., Hakeem, M.J., Selamneni, V., Zhang, P., Draz, M.S., and Ruan, Z. (2021). Engineered CRISPR-Cas Systems for the Detection and Control of Antibiotic-Resistant Infections. J. Nanobiotechnol., 19. · DOI · Paper page
  116. Pursey, 2022, CRISPR-Cas Is Associated with Fewer Antibiotic Resistance Genes in Bacterial Pathogens, Phil. Trans. R. Soc. B, 377, 20200464, 10.1098/rstb.2020.0464 · DOI · Paper page
  117. Wang, 2022, CRISPR-Cas in Acinetobacter baumannii Contributes to Antibiotic Susceptibility by Targeting Endogenous AbaI, Microbiol. Spectr., 10, e00829-22, 10.1128/spectrum.00829-22 · DOI
  118. Gholizadeh, P., Aghazadeh, M., Ghotaslou, R., Rezaee, M.A., Pirzadeh, T., Cui, L., Watanabe, S., Feizi, H., Kadkhoda, H., and Kafil, H.S. (2021). Role of CRISPR-Cas System on Antibiotic Resistance Patterns of Enterococcus faecalis. Ann. Clin. Microbiol. Antimicrob., 20. · DOI
  119. Murugesan, 2022, Analysis of CRISPR–Cas System and Antimicrobial Resistance in Staphylococcus Coagulans Isolates, Lett. Appl. Microbiol., 75, 126, 10.1111/lam.13713 · doi:10.1111/lam.13713
  120. Alduhaidhawi, 2022, Prevalence of CRISPR-Cas Systems and Their Possible Association with Antibiotic Resistance in Enterococcus faecalis and Enterococcus faecium Collected from Hospital Wastewater, Infect. Drug Resist., 15, 1143, 10.2147/IDR.S358248 · DOI · Paper page
  121. Sahu, 2023, Bacteriophages Concept and Applications: A Review on Phage Therapy, Curr. Pharm. Biotechnol., 24, 1245, 10.2174/1389201024666221104142457 · DOI
  122. Ling, 2022, Recent Advances in Bacteriophage-Based Therapeutics: Insight into the Post-Antibiotic Era, Acta Pharm. Sin. B, 12, 4348, 10.1016/j.apsb.2022.05.007 · DOI · Paper page
  123. Dufour, 2017, The Lysis of Pathogenic Escherichia coli by Bacteriophages Releases Less Endotoxin than by β-Lactams, Clin. Infect. Dis., 64, 1582, 10.1093/cid/cix184 · DOI · Paper page
  124. Oechslin, 2017, Synergistic Interaction between Phage Therapy and Antibiotics Clears Pseudomonas aeruginosa Infection in Endocarditis and Reduces Virulence, J. Infect. Dis., 215, 703
  125. Leung, 2017, Modeling the Synergistic Elimination of Bacteria by Phage and the Innate Immune System, J. Theor. Biol., 429, 241, 10.1016/j.jtbi.2017.06.037 · DOI
  126. Durbas, 2022, Phage Therapy: An Old Concept with New Perspectives, J. Appl. Pharm. Sci., 12, 027
  127. Enault, 2017, Phages Rarely Encode Antibiotic Resistance Genes: A Cautionary Tale for Virome Analyses, ISME J., 11, 237, 10.1038/ismej.2016.90 · DOI · Paper page
  128. Suhas, 2022, Structure, Function and Mechanistic Aspects of Scorpion Venom Peptides—A Boon for the Development of Novel Therapeutics, Eur. J. Med. Chem. Rep., 6, 100068
  129. Yacoub, T., Rima, M., Karam, M., Sabatier, J.-M., and Fajloun, Z. (2020). Antimicrobials from Venomous Animals: An Overview. Molecules, 25. · DOI
  130. Ageitos, L., Torres, M.D.T., and De La Fuente-Nunez, C. (2022). Biologically Active Peptides from Venoms: Applications in Antibiotic Resistance, Cancer, and Beyond. Int. J. Mol. Sci., 23. · DOI
  131. Li, 2019, Peptides with Therapeutic Potential in the Venom of the Scorpion Buthus martensii Karsch, Peptides, 115, 43, 10.1016/j.peptides.2019.02.009 · DOI
  132. Zerouti, 2019, Nontoxic Fraction of Scorpion Venom Reduces Bacterial Growth and Inflammatory Response in a Mouse Model of Infection, Toxin Rev., 40, 1
  133. Ahmadi, S., Knerr, J.M., Argemi, L., Bordon, K.C.F., Pucca, M.B., Cerni, F.A., Arantes, E.C., Çalışkan, F., and Laustsen, A.H. (2020). Scorpion Venom: Detriments and Benefits. Biomedicines, 8. · DOI · Paper page
  134. Cesa-Luna, C., Muñoz-Rojas, J., Saab-Rincon, G., Baez, A., Morales-García, Y.E., Juárez-González, V.R., and Quintero-Hernández, V. (2019). Structural Characterization of Scorpion Peptides and Their Bactericidal Activity against Clinical Isolates of Multidrug-Resistant Bacteria. PLoS ONE, 14. · doi:10.1371/journal.pone.0222438
  135. Teerapo, K., Roytrakul, S., Sistayanarain, A., and Kunthalert, D. (2019). A Scorpion Venom Peptide Derivative BmKn‑22 with Potent Antibiofilm Activity against Pseudomonas aeruginosa. PLoS ONE, 14. · DOI
  136. Shi, P., Xie, S., Yang, J., Zhang, Y., Han, S., Su, S., and Yao, H. (2022). Pharmacological Effects and Mechanisms of Bee Venom and Its Main Components: Recent Progress and Perspective. Front. Pharmacol., 13. · DOI
  137. Tiwari, 2022, Melittin: A Natural Peptide with Expanded Therapeutic Applications, Nat. Prod. J., 12, 13
  138. El-Seedi, H., El-Wahed, A.A., Yosri, N., Musharraf, S.G., Chen, L., Moustafa, M., Zou, X., Al-Mousawi, S., Guo, Z., and Khatib, A. (2020). Antimicrobial Properties of Apis mellifera’s Bee Venom. Toxins, 12. · DOI
  139. Hegazi, 2014, Evaluation of the Antibacterial Activity of Bee Venom from Different Sources, World Appl. Sci. J., 30, 266
  140. Fadl, 2018, Antibacterial and Antibiofilm Effects of Bee Venom from (Apis mellifera) on Multidrug-Resistant Bacteria (Mdrb), Al-Azhar J. Pharm. Sci., 58, 60, 10.21608/ajps.2018.46641 · DOI
  141. Choi, 2015, Melittin, a Honeybee Venom-Derived Antimicrobial Peptide, May Target Methicillin-Resistant Staphylococcus aureus, Mol. Med. Rep., 12, 6483, 10.3892/mmr.2015.4275 · DOI
  142. Oguiura, N., Corrêa, P.G., Rosmino, I.L., de Souza, A.O., and Pasqualoto, K.F.M. (2021). Antimicrobial Activity of Snake β-Defensins and Derived Peptides. Toxins, 14. · doi:10.3390/toxins14010001
  143. De Barros, E., Gonçalves, R.M., Cardoso, M.H., Santos, N.C., Franco, O.L., and Cândido, E.S. (2019). Snake Venom Cathelicidins as Natural Antimicrobial Peptides. Front. Pharmacol., 10. · DOI
  144. Blaylock, 2000, Antibacterial Properties of KwaZulu Natal Snake Venoms, Toxicon, 38, 1529, 10.1016/S0041-0101(00)00085-4 · doi:10.1016/s0041-0101(00)00085-4
  145. Dal Mas, C., Rossato, L., Shimizu, T., Oliveira, E.B.D., da Silva Júnior, P.I., Meis, J.F., Colombo, A.L., and Hayashi, M.A.F. (2019). Effects of the Natural Peptide Crotamine from a South American Rattlesnake on Candida auris, an Emergent Multidrug Antifungal Resistant Human Pathogen. Biomolecules, 9. · DOI · Paper page
  146. Bandeira, 2017, Antichagasic Effect of Crotalicidin, a Cathelicidin-like Vipericidin, Found in Crotalus durissus terrificus Rattlesnake’s Venom Gland, Parasitology, 145, 1059, 10.1017/S0031182017001846 · doi:10.1017/s0031182017001846
  147. Franco, 2013, Snake Venoms: Attractive Antimicrobial Proteinaceous Compounds for Therapeutic Purposes, Cell. Mol. Life Sci., 70, 4645, 10.1007/s00018-013-1345-x · DOI
  148. Guo, 2012, Past Decade Study of Snake Venom L-Amino Acid Oxidase, Toxicon, 60, 302, 10.1016/j.toxicon.2012.05.001 · DOI
  149. Oliveira, 2022, The Chemistry of Snake Venom and Its Medicinal Potential, Nat. Rev. Chem., 6, 451, 10.1038/s41570-022-00393-7 · DOI · Paper page
  150. Wang, Y.-J., Wang, L., Yang, H., Xiao, H., Farooq, A., Liu, Z., Hu, M., and Shi, X. (2016). The Spider Venom Peptide Lycosin-II Has Potent Antimicrobial Activity against Clinically Isolated Bacteria. Toxins, 8. · doi:10.3390/toxins8050119
  151. Abreu, 2017, Peptidomics of Acanthoscurria gomesiana Spider Venom Reveals New Toxins with Potential Antimicrobial Activity, J. Proteom., 151, 232, 10.1016/j.jprot.2016.07.012 · doi:10.1016/j.jprot.2016.07.012
  152. Wu, 2019, Spider Venom Peptides as Potential Drug Candidates Due to Their Anticancer and Antinociceptive Activities, J. Venom. Anim. Toxins Incl. Trop. Dis., 25, e146318, 10.1590/1678-9199-jvatitd-14-63-18 · DOI
  153. Gurrola, 2000, Hadrurin, a New Antimicrobial Peptide from the Venom of the Scorpion Hadrurus aztecus, Eur. J. Biochem., 267, 5023, 10.1046/j.1432-1327.2000.01556.x · DOI · Paper page
  154. Corzo, 2001, Characterization of Unique Amphipathic Antimicrobial Peptides from Venom of the Scorpion Pandinus Imperator, Biochem. J., 359, 35, 10.1042/bj3590035 · doi:10.1042/bj3590035
  155. Rodríguez, A., Villegas, E., Montoya-Rosales, A., Rivas-Santiago, B., and Corzo, G. (2014). Characterization of Antibacterial and Hemolytic Activity of Synthetic Pandinin 2 Variants and Their Inhibition against Mycobacterium tuberculosis. PLoS ONE, 9. · DOI
  156. Zeng, 2012, Characterization of BmKbpp, a Multifunctional Peptide from the Chinese Scorpion Mesobuthus martensii Karsch: Gaining Insight into a New Mechanism for the Functional Diversification of Scorpion Venom Peptides, Peptides, 33, 44, 10.1016/j.peptides.2011.11.012 · DOI
  157. Corzo, 2015, Peptides from the Scorpion Vaejovis punctatus with Broad Antimicrobial Activity, Peptides, 73, 51, 10.1016/j.peptides.2015.08.014 · DOI
  158. Guo, 2013, Two Peptides, TsAP-1 and TsAP-2, from the Venom of the Brazilian Yellow Scorpion, Tityus serrulatus: Evaluation of Their Antimicrobial and Anticancer Activities, Biochimie, 95, 1784, 10.1016/j.biochi.2013.06.003 · doi:10.1016/j.biochi.2013.06.003
  159. Cao, 2012, StCT2, a New Antibacterial Peptide Characterized from the Venom of the Scorpion Scorpiops tibetanus, Peptides, 36, 213, 10.1016/j.peptides.2012.04.010 · DOI
  160. Ratajczak, M., Kaminska, D., Matuszewska, E., Hołderna-Kedzia, E., Rogacki, J., and Matysiak, J. (2021). Promising Antimicrobial Properties of Bioactive Compounds from Different Honeybee Products. Molecules, 26. · DOI
  161. Pluta, 2020, Changes in the Expression of Antimicrobial Peptide Genes in Honey Bees (Apis mellifera) under the Influence of Various Pathogens, Ann. Parasitol., 66, 457
  162. Falcao, 2014, Vipericidins: A Novel Family of Cathelicidin-Related Peptides from the Venom Gland of South American Pit Vipers, Amino Acids, 46, 2561, 10.1007/s00726-014-1801-4 · DOI
  163. Blower, 2018, Cathelicidin Peptide Rescues G. mellonella Infected with B. Anthracis, Virulence, 9, 287, 10.1080/21505594.2017.1293227 · doi:10.1080/21505594.2017.1293227
  164. Creane, S.E., Carlile, S.R., Downey, D., Weldon, S., Dalton, J.P., and Taggart, C.C. (2021). The Impact of Lung Proteases on Snake-Derived Antimicrobial Peptides. Biomolecules, 11. · doi:10.3390/biom11081106
  165. Kuhn-Nentwig, L. (2021). Complex Precursor Structures of Cytolytic Cupiennins Identified in Spider Venom Gland Transcriptomes. Sci. Rep., 11. · doi:10.1038/s41598-021-83624-z
  166. Salimo, Z.M., Barros, A.L., Adrião, A.A., Rodrigues, A.M., Sartim, M.A., de Oliveira, I.S., Pucca, M.B., Baia-da-Silva, D.C., Monteiro, W.M., and de Melo, G.C. (2023). Toxins from Animal Venoms as a Potential Source of Antimalarials: A Comprehensive Review. Toxins, 15. · DOI
  167. Rodriguez, C., Carrasco, J., Bruner-Montero, G., Júnior, O.R.P., Gutiérrez, M., and Díaz-Ferguson, E. (2025). Components and Biological Activities of Venom from Lionfishes (Scorpaenidae: Pterois). Mar. Drugs, 23. · doi:10.3390/md23020055
  168. Shin, M.K., Hwang, I.-W., Kim, Y., Kim, S.T., Jang, W., Lee, S., Bang, W.Y., Bae, C.-H., and Sung, J.-S. (2020). Antibacterial and Anti-Inflammatory Effects of Novel Peptide Toxin from the Spider Pardosa astrigera. Antibiotics, 9. · doi:10.3390/antibiotics9070422
  169. Han, 2021, Chemical Modifications to Increase the Therapeutic Potential of Antimicrobial Peptides, Peptides, 146, 170666, 10.1016/j.peptides.2021.170666 · DOI · Paper page
  170. Carratalá, J.V., Serna, N., Villaverde, A., Vázquez, E., and Ferrer-Miralles, N. (2020). Nanostructured Antimicrobial Peptides: The Last Push towards Clinics. Biotechnol. Adv., 44. · DOI
  171. Bellotto, O., Semeraro, S., Bandiera, A., Tramer, F., Pavan, N., and Marchesan, S. (2022). Polymer Conjugates of Antimicrobial Peptides (AMPs) with D-Amino Acids (D-Aa): State of the Art and Future Opportunities. Pharmaceutics, 14. · DOI
  172. Tyagi, 2022, Development of Potential Proteasome Inhibitors against Mycobacterium tuberculosis, J. Biomol. Struct. Dyn., 40, 2189, 10.1080/07391102.2020.1835722 · doi:10.1080/07391102.2020.1835722
  173. Nazir, 2022, Stimuli-Sensitive Drug Delivery Systems for Site-Specific Antibiotic Release, Drug Discov. Today, 27, 1698, 10.1016/j.drudis.2022.02.014 · DOI · Paper page
  174. Kassinger, 2020, Biofilm Architecture: An Emerging Synthetic Biology Target, Synth. Syst. Biotechnol., 5, 1, 10.1016/j.synbio.2020.01.001 · DOI · Paper page
  175. Mukherjee, R., Vidic, J., Leal, E., da Costa, A.C., Prudencio, C.R., Raj, V.S., Chang, C.-M., and Pandey, R.P. (2023). Nanobiotics and the One Health Approach: Boosting the Fight Against Antimicrobial Resistance at the Nanoscale. Biomolecules, 13. · DOI
  176. Elfadil, 2022, Promising Advances in Nanobiotic-Based Formulations for Drug Specific Targeting Against Multidrug-Resistant Microbes and Biofilm-Associated Infections, Microb. Pathog., 170, 105721, 10.1016/j.micpath.2022.105721 · DOI
  177. Mohamed, 2021, Nanobiotic Formulations as Promising Advances for Combating MRSA Resistance: Susceptibilities and Post-Antibiotic Effects of Clindamycin, Doxycycline, and Linezolid, RSC Adv., 11, 39696, 10.1039/D1RA08639A · DOI
  178. Milewska, 2021, Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment, Int. J. Nanomed., 16, 6593, 10.2147/IJN.S323831 · DOI
  179. Chakraborty, N., Jha, D., Roy, I., Kumar, P., Gaurav, S.S., Marimuthu, K., Ng, O.-T., Lakshminarayanan, R., Verma, N.K., and Gautam, H.K. (2022). Nanobiotics against Antimicrobial Resistance: Harnessing the Power of Nanoscale Materials and Technologies. J. Nanobiotechnol., 20. · DOI · Paper page
  180. Makabenta, 2021, Nanomaterial-Based Therapeutics for Antibiotic-Resistant Bacterial Infections, Nat. Rev. Microbiol., 19, 23, 10.1038/s41579-020-0420-1 · DOI · Paper page
  181. Geersing, 2019, Folic Acid Conjugates of a Bleomycin Mimic for Selective Targeting of Folate Receptor Positive Cancer Cells, Bioorganic Med. Chem. Lett., 29, 1922, 10.1016/j.bmcl.2019.05.047 · doi:10.1016/j.bmcl.2019.05.047
  182. Tripathi, 2022, Recent Advances and Mechanistic Insights into Antibacterial Activity, Antibiofilm Activity, and Cytotoxicity of Silver Nanoparticles, ACS Appl. Bio Mater., 5, 1391, 10.1021/acsabm.2c00014 · DOI · Paper page
  183. Wagi, 2020, Bacterial Nanobiotic Potential, Green Process. Synth., 9, 203, 10.1515/gps-2020-0021 · doi:10.1515/gps-2020-0021
  184. Brown, 2012, Nanoparticles Functionalized with Ampicillin Destroy Multiple-Antibiotic-Resistant Isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and Methicillin-Resistant Staphylococcus aureus, Appl. Environ. Microbiol., 78, 2768, 10.1128/AEM.06513-11 · DOI · Paper page
  185. Okkeh, M., Bloise, N., Restivo, E., De Vita, L., Pallavicini, P., and Visai, L. (2021). Gold Nanoparticles: Can. They Be the Next Magic. Bullet for Multidrug-Resistant Bacteria?. Nanomaterials, 11. · DOI
  186. Cheng, 2022, pH-Triggered Size-Tunable Silver Nanoparticles: Targeted Aggregation for Effective Bacterial Infection Therapy, Small, 18, 2200915, 10.1002/smll.202200915 · DOI · Paper page
  187. Mamun, M.M., Sorinolu, A.J., Munir, M., and Vejerano, E.P. (2021). Nanoantibiotics: Functions and Properties at the Nanoscale to Combat Antibiotic Resistance. Front. Chem., 9. · DOI
  188. Chung, 2013, A Magneto-DNA Nanoparticle System for Rapid Detection and Phenotyping of Bacteria, Nat. Nanotechnol., 8, 369, 10.1038/nnano.2013.70 · DOI · Paper page
  189. Kulshrestha, 2016, Calcium Fluoride Nanoparticles Induced Suppression of Streptococcus Mutans Biofilm: An In Vitro and In Vivo Approach, Appl. Microbiol. Biotechnol., 100, 1901, 10.1007/s00253-015-7154-4 · DOI
  190. Wang, 2021, Liposome as a Delivery System for the Treatment of Biofilm-mediated Infections, J. Appl. Microbiol., 131, 2626, 10.1111/jam.15053 · DOI
  191. Cano, A., Ettcheto, M., Espina, M., López-Machado, A., Cajal, Y., Rabanal, F., Sánchez-López, E., Camins, A., García, M.L., and Souto, E.B. (2020). State-of-the-Art Polymeric Nanoparticles as Promising Therapeutic Tools against Human Bacterial Infections. J. Nanobiotechnol., 18. · DOI
  192. Forier, 2014, Lipid and Polymer Nanoparticles for Drug Delivery to Bacterial Biofilms, J. Control. Release, 190, 607, 10.1016/j.jconrel.2014.03.055 · DOI · Paper page
  193. Rajendiran, K., Zhao, Z., Pei, D.-S., and Fu, A. (2019). Antimicrobial Activity and Mechanism of Functionalized Quantum Dots. Polymers, 11. · DOI
  194. Courtney, 2016, Photoexcited Quantum Dots for Killing Multidrug-Resistant Bacteria, Nature Mater., 15, 529, 10.1038/nmat4542 · DOI · Paper page
  195. Kalhapure, 2015, Nanoengineered Drug Delivery Systems for Enhancing Antibiotic Therapy, J. Pharm. Sci., 104, 872, 10.1002/jps.24298 · DOI · Paper page
  196. Gupta, 2024, Construction, Features and Regulatory Aspects of Organ-Chip for Drug Delivery Applications: Advances and Prospective, Curr. Pharm. Des., 30, 1952, 10.2174/0113816128305296240523112043 · DOI
  197. Lazar, V., Oprea, E., and Ditu, L. (2023). Resistance, Tolerance, Virulence and Bacterial Pathogen Fitness—Current State and Envisioned Solutions for the near Future. Pathogens, 12. · DOI
  198. Kulchar, R.J., Singh, R., Ding, S., Alexander, E., Leong, K.W., and Daniell, H. (2023). Delivery of Biologics: Topical Administration. Biomaterials, 302. · DOI
  199. Aslam, 2018, Antibiotic Resistance: A Rundown of a Global Crisis, Infect. Drug Resist., 11, 1645, 10.2147/IDR.S173867 · DOI · Paper page

Cited by

Metadata

Authors
Elshobary, M. E., Badawy, N. K., Ashraf, Y., Zatioun, A. A., Masriya, H. H., Ammar, M. M., Mohamed, N. A., Mourad, S., & Assy, A. M.
Venue
Pharmaceuticals
Publisher
MDPI AG
Published
2025-03-12
Volume
18
Issue
3
Pages
402
ISSN
1424-8247
Cited by
268
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.